Transcriptome profiling of bulk CD11b+ cells isolated from human glioblastomas (GBMs) and rodent gliomas showed a mixture of protumorigenic and antitumorigenic phenotypes, and did not reveal consistent markers and pathways4–6. The gene discussed is ITGAM; the disease is central nervous system cancer.